Teva shareholder sues after $450m US settlement

At the end of last week, Teva Pharmaceuticals Industries (TASE: TEVA; NYSE: TEVA) announced that it had reached a settlement with the US Department of Justice and would pay penalties totaling $450 million, payable over six years,…